Crohn's Therapy, Resource, Evaluation, and Assessment Tool Registry
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2013
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms TREAT
- Sponsors Centocor; Janssen Biotech
- 13 Aug 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 01 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Apr 2012 Additional lead trial centre (Janssen Biotech, Inc.) and actual patient number 6273 added as reported by ClinicalTrials.gov.